| Literature DB >> 32826640 |
Lee M Margolis1, Jillian T Allen, Adrienne Hatch-McChesney1, Stefan M Pasiakos1.
Abstract
INTRODUCTION/Entities:
Mesh:
Substances:
Year: 2021 PMID: 32826640 PMCID: PMC7803445 DOI: 10.1249/MSS.0000000000002476
Source DB: PubMed Journal: Med Sci Sports Exerc ISSN: 0195-9131
FIGURE 1PRISMA meta-regression search strategy diagram.
Study design for isocaloric interventions.
| Study | Sample Size ( | Exercise Type | Exercise Time (min) | Recovery Time (h) | Treatment | Energy (kcal) | CHO (g) | Pro (g) | CHO (g·kg−1⋅h−1) | Pro (g·kg−1⋅h−1) | Glycogen Synthesis | Glycogen Measurement Method |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alghannam et al. ( | 6 (5M, 1F) | Treadmill running; Time to exhaustion 70% V˙O2max | 82 | 4 | CHO | 1277 | 319.2 | 1.20 | 37.4 | Plate assay, dry weight | ||
| CHO-PRO | 1277 | 212.8 | 106.4 | 0.80 | 0.40 | 41.7 | ||||||
| Carrithers et al. ( | 7 (7M) | Cycle ergometry 70% V˙O2max; sprint to exhaustion | 82.5 | 4 | CHO | 1206 | 301.6 | 1.00 | 31 | Plate assay, dry weight | ||
| CHO-PRO | 1206 | 259.3 | 42.2 | 0.86 | 0.14 | 28 | ||||||
| Cogan et al. ( | 11 (11M) | Cycle ergometry 70% V˙O2max | 120 | 4 | CHO | 720 | 180 | 0.60 | 0.58 | Plate assay, wet weight | ||
| CHO-PRO | 720 | 156 | 24 | 0.52 | 0.08 | 0.52 | ||||||
| Detko et al. ( | 7 (7M) | Intermittent cycle ergometry; 70% and 120% V˙O2max | 120 | 4 | CHO | 1516 | 379 | 1.20 | 5.8 | Magnetic resonance spectroscopy | ||
| CHO-PRO | 1516 | 253 | 126 | 0.80 | 0.40 | 3.7 | ||||||
| Ferguson-Stegall et al. ( | 10 (5M, 5F) | Cycle ergometry 70% V˙O2max; intervals 45% and 90% V˙O2max | 100 | 4 | CHO | 949 | 181.8 | 0.67 | 30.6 | Plate assay, wet weight | ||
| CHO-PRO | 949 | 137.8 | 44 | 0.51 | 0.16 | 23.9 | ||||||
| Howarth et al. ( | 6 (6M) | Intermittent cycle ergometer; 50%–80% V˙O2max | 120 | 4 | CHO | 1728 | 432 | 1.20 | 25 | Plate assay, dry weight | ||
| CHO-PRO | 1728 | 324 | 108 | 0.90 | 0.30 | 25 | ||||||
| Ivy et al. ( | 7 (7M) | Cycle ergometry 65%–75% V˙O2max; sprint to exhaustion | 150 | 4 | CHO | 640 | 160 | 0.54 | 8.4 | Magnetic resonance spectroscopy | ||
| CHO-PRO | 864 | 160 | 56 | 0.54 | 0.19 | 12.0 | ||||||
| Lunn et al. ( | 6 (6M) | Treadmill running 65% V˙O2max | 45 | 3 | CHO | 296 | 74 | 0.32 | −0.1 | Plate assay, wet weight | ||
| CHO-PRO | 296 | 58 | 16 | 0.25 | 0.07 | 0 | ||||||
| Roy et al. ( | 10 (10M) | Whole-body resistance exercise: 9 exercises/3 sets 80% 1RM | NR | 4.5 | CHO | 694 | 173.6 | 0.44 | 19.3 | Plate assay, dry weight | ||
| CHO-PRO | 694 | 114.5 | 40 | 0.29 | 0.10 | 23.0 | ||||||
| van Loon et al. ( | 8 (8M) | Intermittent cycle ergometer; 50%–90% V˙O2max | 100 | 5 | CHO | 1680 | 420 | 1.20 | 44.8 | Plate assay, dry weight | ||
| CHO-PRO | 1680 | 280 | 140 | 0.80 | 0.40 | 35.4 |
Values are presented as mean.
mmol·kg−1 muscle dry weight·h−1.
μg·mg−1 muscle wet weight·h−1.
mmol·L−1·h−1.
μmol·g−1 muscle wet weight·h−1.
g per 100 g wet muscle weight·h−1.
M, males; F, females.
Study design for nonisocaloric interventions.
| Study | Sample Size ( | Exercise Type | Exercise Time (min) | Recovery Time (h) | Treatment | Energy (kcal) | CHO (g) | Pro (g) | CHO (g·kg−1⋅h−1) | Pro (g·kg−1⋅h−1) | Glycogen Synthesis | Glycogen Measurement Method |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beelen et al. ( | 14 (14M) | Intermittent cycle ergometer; 50%–90% V˙O2max | 106 | 4 | CHO | 2062 | 515.5 | 1.80 | 31 | Plate assay, dry weight | ||
| CHO-PRO | 2578 | 515.5 | 128.9 | 1.80 | 0.45 | 34 | ||||||
| Betts et al. ( | 6 (6M) | Treadmill running; 70% V˙O2max | 90 | 4 | CHO | 945 | 236.2 | 0.80 | 12.3 | Plate assay, dry weight | ||
| CHO-PRO | 1299 | 236.2 | 88.6 | 0.80 | 0.30 | 12.1 | ||||||
| Howarth et al. ( | 6 (6M) | Intermittent cycle ergometer; 50%–80% V˙O2max | 120 | 4 | CHO | 1296 | 324 | 0.90 | 23 | Plate assay, dry weight | ||
| CHO-PRO | 1728 | 324 | 108 | 0.90 | 0.30 | 25 | ||||||
| Ivy et al. ( | 7 (7M) | Cycle ergometry 70% V˙O2max; sprint to exhaustion | 150 | 4 | CHO | 864 | 216 | 0.73 | 7.3 | Magnetic resonance spectroscopy | ||
| CHO-PRO | 864 | 160 | 56 | 0.54 | 0.19 | 12.0 | ||||||
| Jentjens et al. ( | 8 (8M) | Intermittent cycle ergometer 50%–90% V˙O2max | 135 | 3 | CHO | 1002 | 250.6 | 1.20 | 40 | Plate assay, dry weight | ||
| CHO-PRO | 1336 | 250.6 | 83.5 | 1.20 | 0.40 | 25 | ||||||
| Kammer et al. ( | 12 (8M, 4F) | Cycle ergometry 60%–65% V˙O2max | 120 | 2 | CHO | 314 | 78.5 | 1.10 | 6.2 | Plate assay, wet weight | ||
| CHO-PRO | 410 | 77 | 19.5 | 1.08 | 0.27 | 7.3 | ||||||
| Tarnopolsky et al. ( | 16 (8M, 8F) | Cycle ergometry 65% V˙O2max | 90 | 4 | CHO | 536 | 134 | 0.50 | 37.2 | Plate assay, dry weight | ||
| CHO-PRO | 480 | 100.5 | 13.4 | 0.38 | 0.05 | 24.6 | ||||||
| van Loon et al. ( | 8 (8M) | Intermittent cycle ergometer; 50%–90% V˙O2max | 100 | 5 | CHO | 1120 | 280 | 0.80 | 16.4 | Plate assay, dry weight | ||
| CHO-PRO | 1680 | 280 | 140 | 0.80 | 0.40 | 35.4 | ||||||
| Van Hall et al. ( | 5 (5M) | Intermittent cycle ergometer 50%–90% V˙O2max | NR | 4 | CHO | 492 | 123 | 0.42 | 39.8 | Plate assay, dry weight | ||
| CHO-PRO | 640 | 123 | 37 | 0.42 | 0.13 | 36.5 | ||||||
| Van Hall et al. ( | 8 (8M) | Intermittent cycle ergometer 50%–90% V˙O2max | NR | 3 | CHO | 692 | 173 | 0.80 | 28.0 | Plate assay, dry weight | ||
| CHO-PRO | 952 | 173 | 65 | 0.80 | 0.30 | 34.0 | ||||||
| Williams et al. ( | 8 (8M) | Intermittent cycle ergometer 65%–85% V˙O2max | 120 | 4 | CHO | 168 | 42 | 0.16 | 17.3 | Plate assay, dry weight | ||
| CHO-PRO | 536 | 106 | 28 | 0.39 | 0.10 | 39.8 | ||||||
| Yaspelkis et al. ( | 12 (12M) | Intermittent cycle ergometer 50%–80% V˙O2max | 120 | 3 | CHO | 864 | 216 | 1.00 | 6.0 | Plate assay, wet weight | ||
| CHO-PRO | 933 | 216 | 17.3 | 1.00 | 0.08 | 8.2 | ||||||
| Zawadzki et al. ( | 9 (9M) | Intermittent cycle ergometer 50%–85% V˙O2max | 120 | 4 | CHO | 896 | 224 | 0.77 | 26.7 | Plate assay, wet weight | ||
| CHO-PRO | 1222 | 224 | 81.4 | 0.77 | 0.28 | 35.5 |
Values are presented as mean.
mmol·kg−1 muscle dry weight·h−1.
mmol·L−1·h−1.
μmol·g−1 muscle wet weight·h−1.
μmol·g−1 muscle protein concentration.
M, males; F, females.
Energy, protein, and carbohydrate intake for subgroup analysis.
| Subgroup | Treatment | Energy (kcals) | Carbohydrate (g) | Protein (g) | Carbohydrate (g·kg−1⋅h−1) | Protein (g·kg−1⋅h−1) |
|---|---|---|---|---|---|---|
| Isocaloric | CHO | 1093 ± 469 | 268 ± 120 | – | 0.86 ± 0.34 | – |
| CHO-PRO | 1093 ± 469 | 195 ± 84 | 70 ± 45 | 0.63 ± 0.24 | 0.22 ± 0.14 | |
| Nonisocaloric | CHO | 848 ± 485 | 212 ± 121 | – | 0.84 ± 0.41 | – |
| CHO-PRO | 1128 ± 613 | 214 ± 117 | 67 ± 43 | 0.85 ± 0.39 | 0.26 ± 0.14 | |
| High carbohydrate | CHO | 1208 ± 483 | 302 ± 117 | – | 1.10 ± 0.27 | – |
| CHO-PRO | 1409 ± 519 | 262 ± 100 | 90 ± 43 | 0.98 ± 0.28 | 0.33 ± 0.12 | |
| Low carbohydrate | CHO | 625 ± 256 | 151 ± 59 | – | 0.52 ± 0.19 | – |
| CHO-PRO | 727 ± 263 | 134 ± 45 | 40 ± 21 | 0.46 ± 0.15 | 0.24 ± 0.14 |
Values are presented as mean ± SD. High carbohydrate, ≥0.8 g·kg−1⋅h−1; low carbohydrate, <0.8 g·kg−1⋅h−1.
FIGURE 2Values are presented as ES (95% CI) stratified by energy content.
FIGURE 3Values are presented as ES (95% CI) stratified by median relative carbohydrate content (high carbohydrate, ≥0.8 g·kg−1⋅h−1; low carbohydrate, <0.8 g·kg−1⋅h−1).